Skip to main content
Brain logoLink to Brain
. 2023 Mar 30;146(8):e61. doi: 10.1093/brain/awad097

Correction to: mTORC1 functional assay reveals SZT2 loss-of-function variants and a founder in-frame deletion

PMCID: PMC10393390  PMID: 36996274

Jeffrey D. Calhoun, Miriam C. Aziz, Hannah C. Happ, Jonathan Gunti, Colleen Gleason, Najma Mohamed, Kristy Zeng, Meredith Hiller, Emily Bryant, Divakar S. Mithal, Irena Bellinski, Lisa Kinsley, Mona Grimmel, Eva M. C. Schwaibold, Constance Smith-Hicks, Anna Chassevent, Marcello Scala, Andrea Accogli, Annalaura Torella, Pasquale Striano, Valeria Capra, Lynne M. Bird, Issam Ben-Sahra, Nina Ekhilevich, Tova Hershkovitz, Karin Weiss, John Millichap, Elizabeth E. Gerard, Gemma L. Carvill. mTORC1 functional assay reveals SZT2 loss-of-function variants and a founder in-frame deletion. Brain. 2022;145:1939–1948. https://doi.org/10.1093/brain/awab451

In the originally published version of this manuscript, there was an error in the affiliation assigned to author Mona Grimmel. This should read ‘3 Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany’ instead of ‘3 Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Epilepsy Center and Division of Neurology, Chicago, IL 60610, USA’.

The error has been corrected in the article.


Articles from Brain are provided here courtesy of Oxford University Press

RESOURCES